Drug intelligence / Profile preview

eicosapentaenoic acid

Development stage
Approved
Lead developer
Amarin
Modality
Small Molecules
Administration
Oral
01

Overview

**Eicosapentaenoic acid** is a C20 polyunsaturated omega-3 fatty acid found in fish oils and other marine lipid sources. In biological systems, the naturally occurring all-cis form is incorporated into membrane phospholipids and serves as a precursor of omega-3-derived eicosanoids, including prostaglandin-3 and thromboxane-3 series mediators; it can also alter arachidonic-acid eicosanoid metabolism. The unqualified chemical name is stereochemically nonspecific, although nutritional and clinical literature commonly uses it to refer to naturally occurring all-cis EPA. It has been studied as an oral intervention, including in colorectal cancer liver metastases. It must not be conflated with **icosapent ethyl**, the distinct ethyl-ester pharmaceutical active ingredient in Vascepa. ([pubchem.ncbi.nlm.nih.gov](https://pubchem.ncbi.nlm.nih.gov/compound/Icosapent))

Brand names
Vascepa
Other names
EPAeicosa-5,8,11,14,17-pentaenoic acideicosapentanoic acid
02

Targets

FFAR4 (Free fatty acid receptor 4)PPARG (Peroxisome proliferator-activated receptor gamma)VNUT (Vesicular nucleotide transporter)

Beyond the preview

Go deeper on eicosapentaenoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on eicosapentaenoic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call